Thus, we used those HNSCC cell lines to perform the in vitro and in vivo models for clarifying the role of RUNX2 in regulating the transcription of PTHLH during HNSCC progression in this study. The gene discussed is PTHLH; the disease is head and neck squamous cell carcinoma.